Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth.
about
Extracellular Matrix-Inspired Growth Factor Delivery Systems for Skin Wound HealingDepot-Based Delivery Systems for Pro-Angiogenic Peptides: A ReviewExtracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineExtracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.Bone tissue engineering: recent advances and challengesThe tumor as an organ: comprehensive spatial and temporal modeling of the tumor and its microenvironmentClinical translation of controlled protein delivery systems for tissue engineeringStem cells, growth factors and scaffolds in craniofacial regenerative medicineControlled release of recombinant human cementum protein 1 from electrospun multiphasic scaffold for cementum regenerationAdvancing Tissue Engineering: A Tale of Nano-, Micro-, and Macroscale Integration.A red/far-red light-responsive bi-stable toggle switch to control gene expression in mammalian cellsStrain tunes proteolytic degradation and diffusive transport in fibrin networksEffects of VEGF temporal and spatial presentation on angiogenesis.Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164Molecular mediators of angiogenesis.Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model.Bioartificial matrices for therapeutic vascularizationStructural basis for the nonlinear mechanics of fibrin networks under compression.Characterization of the chemotactic and mitogenic response of SMCs to PDGF-BB and FGF-2 in fibrin hydrogelsSynergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism.Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine.Engineered materials and the cellular microenvironment: a strengthening interface between cell biology and bioengineering.Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.Biomaterials for craniofacial bone engineering.Growth factor delivery-based tissue engineering: general approaches and a review of recent developmentsSpatially directed guidance of stem cell population migration by immobilized patterns of growth factors.Application of AMOR in craniofacial rabbit bone bioengineering.Enhancement of capillary and cellular ingrowth in ePTFE implants with a proangiogenic recombinant construct derived from fibronectin.Application of microtechnologies for the vascularization of engineered tissues.Biomaterial-mediated modification of the local inflammatory environment.Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healingPreventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterialsEngineering growth factors for regenerative medicine applications.Functionalization of Carbon Nanomaterial Surface by Doxorubicin and Antibodies to Tumor Markers.Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges.Building vascular networks.Controlled Angiogenesis in Peptide Nanofiber Composite HydrogelsThe effect of vascular endothelial growth factor (VEGF) presentation within fibrin matrices on endothelial cell branchingStromal cell identity influences the in vivo functionality of engineered capillary networks formed by co-delivery of endothelial cells and stromal cells.
P2860
Q26798452-F526CB69-5F87-4510-AC38-6917434739FBQ26799856-58EB61C9-C775-48D9-9A95-9B305DDAD1AFQ26829783-1E27EC3B-1C75-48E2-94C0-A5898CC9016EQ27000351-6FCCAD68-37FD-47B6-8CDC-5043BA728B6EQ27007788-71FA482C-E484-4E72-B564-7540A1515D0CQ27318697-2E57AB37-3B4F-421A-ADCB-12221186F8B5Q28084738-66FC3D4B-A0BA-4E20-B173-E6DA27B7A8EFQ28395149-7CF1E7CB-F829-4002-9274-2845809E93D0Q28829906-70450062-0A6E-48FF-8D37-415A08540AC8Q30358039-F249805F-27CC-4A82-B3A5-C2123FADDCADQ30538905-7130B337-D1DD-4718-86D4-2A4D824FD8B2Q30542430-453C40B2-9389-4A5F-A2E2-F04A4442929BQ33620964-826C85C8-DE7E-499E-8539-D6AE556376A9Q33627325-188E2F2E-06D8-43E6-8E4F-D5D853FC53A1Q33639474-E478EE01-E014-481E-B732-3742B08C7CCDQ33649673-355447AC-E321-4946-B0E5-423AC651C549Q33734474-BB1625E2-2832-4577-84F1-01739513EB27Q33924476-463EAEDC-309B-4E63-94F7-24B8FC088927Q34083818-508FCA03-2DE6-4D52-94F6-C1213F200262Q34115816-022299CE-948E-4281-83AE-D5A38651FB4CQ34204037-D36E9004-98D5-4297-A152-6680A7E008B4Q34348884-D5CE3178-5154-42E4-A4CF-426067D7A5E5Q34479397-45546B36-279E-466E-B136-7A628EC9057AQ34543454-F8408A0B-5BB1-4567-864F-8FC5AD811C63Q34548765-549F25F4-27BA-44D3-979C-CF2F03B23905Q34771611-18851779-0749-40D2-B73C-58DF20DDA03FQ35075242-0917C3FB-D573-41FB-B55A-EC8EDA62F674Q35219443-C5BC6FFD-73FE-4FC7-9024-50BBC60C12B9Q35608143-F73FD9C5-29BF-44D5-8E72-DD47543A08B4Q35609496-5BCC4EF7-4A16-47C7-82C8-5A34E43AC089Q35618768-C61545E2-7904-4CF0-B876-FF4A7DEEA412Q35641546-656F8740-358F-4E96-B26A-5C8389EEDBA0Q35837032-B4B85052-2870-4F66-B78B-3B1B97C3EADDQ35837394-C7B6B347-6D3B-45D6-BB49-46765AB4B38FQ36064150-5D1CAE52-F352-40DD-A7E6-03CE0260338BQ36419601-710A5E1A-441F-4D1E-AF16-66C886E96A6EQ36600373-45BC770F-F0FA-468C-A07E-E81414C7998DQ36623213-6289C20D-4AB9-4C14-9C24-1499B6FD52CAQ36697467-AE8B285C-2CBC-4E07-999A-B3203FF11F3EQ36720770-DE058D35-CE0A-48B0-9B52-577283C5752C
P2860
Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Cell-demanded liberation of VE ...... ontrolled blood vessel growth.
@en
Cell-demanded liberation of VE ...... ontrolled blood vessel growth.
@nl
type
label
Cell-demanded liberation of VE ...... ontrolled blood vessel growth.
@en
Cell-demanded liberation of VE ...... ontrolled blood vessel growth.
@nl
prefLabel
Cell-demanded liberation of VE ...... ontrolled blood vessel growth.
@en
Cell-demanded liberation of VE ...... ontrolled blood vessel growth.
@nl
P2093
P1433
P1476
Cell-demanded liberation of VE ...... ontrolled blood vessel growth.
@en
P2093
Andreas H Zisch
Christian Schnell
Georg Martiny-Baron
Jeanette Wood
Martin Ehrbar
Peter H Burri
Ursula Schenk
Valentin G Djonov
P304
P356
10.1161/01.RES.0000126411.29641.08
P577
2004-03-25T00:00:00Z